Levi & Korsinsky Reminds Sage Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 - SAGEAccesswire • 10/21/24
Sage Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Sage Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 - SAGEAccesswire • 10/21/24
SAGE SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Sage Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • 10/21/24
SAGE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Sage Therapeutics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • 10/20/24
SAGE DEADLINE: RLF, A TOP-RANKED LAW FIRM, Encourages Sage Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 28 Deadline in Securities Class Action – SAGEGlobeNewsWire • 10/20/24
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Sage Therapeutics, Inc. (SAGE)GlobeNewsWire • 10/18/24
ROSEN, A TOP-RANKED LAW FIRM, Encourages Sage Therapeutics, Inc. Investors to Secure Counsel Before Important October 28 Deadline in Securities Class Action – SAGEGlobeNewsWire • 10/18/24
Sage Therapeutics' stock lower as biotech unveils plan to cut 33% of workforceMarket Watch • 10/17/24
Sage Therapeutics Announces Strategic Reorganization to Prioritize ZURZUVAE® Commercialization and Focus its Development PortfolioBusiness Wire • 10/17/24
Shareholders of Sage Therapeutics, Inc. Should Contact The Gross Law Firm Before October 28, 2024 to Discuss Your Rights - SAGEPRNewsWire • 10/17/24
Sage Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – SAGEAccesswire • 10/16/24
Levi & Korsinsky Notifies Shareholders of Sage Therapeutics, Inc.(SAGE) of a Class Action Lawsuit and an Upcoming DeadlineAccesswire • 10/16/24
The Gross Law Firm Reminds Sage Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 – SAGEGlobeNewsWire • 10/16/24
Investors who lost money on Sage Therapeutics, Inc.(SAGE) should contact Levi & Korsinsky about pending Class Action - SAGEAccesswire • 10/16/24
October 28, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against SAGEAccesswire • 10/16/24
Shareholders that lost money on Sage Therapeutics, Inc.(SAGE) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreAccesswire • 10/16/24
SAGE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Sage Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • 10/16/24
Class Action Filed Against Sage Therapeutics, Inc. (SAGE) - October 28, 2024 Deadline to Join - Contact Levi & KorsinskyAccesswire • 10/15/24
Shareholders that lost money on Sage Therapeutics, Inc.(SAGE) should contact Levi & Korsinsky about pending Class Action - SAGEAccesswire • 10/15/24
Sage Therapeutics, Inc. Is Being Sued For Violating Securities Laws And Shareholders Are Urged To Contact The Schall Law FirmAccesswire • 10/15/24
SAGE SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Sage Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!Accesswire • 10/15/24
Sage Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, October 29, 2024Business Wire • 10/15/24
